Role of Lymphatics in Ovarian Cancer
Author Information
Author(s): Sundar S S, Zhang H, Brown P, Manek S, Han C, Kaur K, Charnock M F L, Jackson D, Ganesan T S
Primary Institution: Ovarian Cancer Group, Cancer Research UK Molecular Oncology Laboratories, John Radcliffe Hospital, Oxford, UK
Hypothesis
The study investigates the significance of lymphatic count, vascular count, and angiogenic growth factors in epithelial ovarian cancer to understand the pathogenesis of metastasis.
Conclusion
Lymphatic count may aid in metastasis in ovarian cancer but does not have clear prognostic significance on its own.
Supporting Evidence
- On multivariate analysis, bulky residual disease after surgery was the best prognostic indicator for progression-free and overall survival.
- Lymphatic count was statistically significant as a prognostic factor for progression-free and overall survival.
- Dissemination of ovarian cancer does not occur primarily through vascular or lymphatic routes but may occur through direct intraperitoneal spread.
Takeaway
This study looked at how lymphatic vessels might help cancer spread in women with ovarian cancer, but found that just having more lymphatic vessels doesn't always mean worse outcomes.
Methodology
The study analyzed tumor specimens using immunohistochemistry to assess lymphatic and vascular counts and their association with survival outcomes.
Limitations
The study did not find a correlation between lymphatic count and several clinical factors, and lymphatic count did not predict survival curves.
Participant Demographics
The study included 108 women diagnosed with epithelial ovarian carcinoma, with a median age of 63 years.
Statistical Information
P-Value
P<0.001 for residual disease; P=0.05 for lymphatic count in progression-free survival; P=0.04 for overall survival.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website